Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology

Endocrine. 2023 Apr;80(1):1-9. doi: 10.1007/s12020-022-03236-z. Epub 2022 Oct 30.

Abstract

Primary adrenal insufficiency (PAI) is an endocrine disorder characterized by direct adrenal failure, with consequent glucocorticoid, and eventually mineralocorticoid, deficiency. In children, the main cause of PAI is congenital adrenal hyperplasia (CAH), due to a loss of function of adrenal steroidogenic enzymes, but also rarer forms, including autoimmune polyglandular syndrome, adrenoleucodistrophy, adrenal hypoplasia congenita, familial glucocorticoid deficiency, and Allgrove's Syndrome, may be observed. In PAI children, growth alterations represent a major issue, as both inadequate and excessive glucocorticoid replacement treatment may lead to reduced growth rate and adult height impairment. However, growth abnormalities are poorly studied in rare forms of paediatric PAI, and specific studies on growth rate in these children are currently lacking. In the present review, the currently available evidence on growth alterations in children with rare PAI forms will be summarized, with a major focus on comorbidities with a potential impact on patients' growth rate.

Keywords: Adrenal insufficiency; Children; Growth; Growth rate; Height; Primay adrenal insufficiency.

Publication types

  • Review

MeSH terms

  • Addison Disease*
  • Adrenal Hyperplasia, Congenital*
  • Adrenal Insufficiency* / etiology
  • Adult
  • Child
  • Endocrinology*
  • Glucocorticoids / therapeutic use
  • Humans

Substances

  • Glucocorticoids